Prevention of REStinosis with Tranilast & its Outcomes (PRESTO) trial
Jump to navigation
Jump to search
Introduction
Results:
- patients with diabetes mellitus type 2 had higher* rates of complications after percutaneous coronary intervention than non-diabetics
- death 2.1% vs 0.9%
- myocardial infarction 1.9% vs 1.2%
- revascularization of the target vessel 17.9% vs 12.8%
More general terms
References
- ↑ Journal Watch 24(8):62, 2004
Mathew V et al Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation 109:476, 2004 PMID: https://www.ncbi.nlm.nih.gov/pubmed/14732749